Hc Surgical Specialists LtdSGX: 1B1

Unaudited Financial Statements and Dividend Announcement for the Second Half and Twelve Months Ended 31 May 2022 Result Announcement | Press Release

· Issued by HC Surgical Specialists Ltd

HC Surgical Specialists Limited

Condensed interim financial statements

For the six months and full year ended 31 May 2023

1

Table of Contents

  1. Condensed interim consolidated statement of profit of loss and other comprehensive

income …

3

B.

Condensed interim statements of financial position …

4

C.

Condensed interim statements of changes in equity …

6

D.

Condensed interim consolidated statement of cash flows …

9

E.

Notes to the condensed interim consolidated financial statements …

11

F.

Other information required pursuant to Appendix 7C of the Catalist Rules

30

2

A. Condensed interim consolidated statement of profit or loss and other comprehensive income

Group

6 months ended

12 months ended

31 May 2023

31 May 2022

31 May 2023

31 May 2022

Note

(Unaudited)

(Unaudited)

Change

(Unaudited)

(Audited)

Change

S$'000

S$'000

%

S$'000

S$'000

%

Revenue

4.2

8,959

8,902

0.6%

19,077

19,311

‐1.2%

Other items of income

Other income

612

327

87.2%

1,476

1,456

1.4%

Gain on derecognition of financial

assets

‐

379

N.M.

‐

379

N.M.

Gain/(loss) on modification of

other financial liabilities and

deferred consideration

57

‐

N.M.

(262)

‐

N.M.

Fair value (loss)/gain on financial

assets at FVTPL

‐

(81)

N.M.

‐

608

N.M.

Items of expense

Changes in inventories

92

23

300.0%

69

51

35.3%

Inventories, consumables and

surgery expenses

(1,334)

(1,259)

6.0%

(2,697)

(2,695)

0.1%

Employee benefits expense

(3,365)

(3,328)

1.1%

(6,646)

(6,823)

‐2.6%

Depreciation and amortisation

(915)

(807)

13.4%

(1,744)

(1,669)

4.5%

Lease expenses

(12)

(21)

‐42.9%

(21)

(57)

‐63.2%

Fair value loss on derivative

financial instruments

(332)

‐

N.M.

(49)

‐

N.M.

Fair value loss on financial assets

at FVTPL

(840)

‐

N.M.

(1,742)

‐

N.M.

Other expenses

(1,345)

(1,524)

‐11.7%

(2,772)

(2,340)

18.5%

Finance costs

(348)

(376)

‐7.4%

(636)

(474)

34.2%

Profit before income tax

6.1

1,229

2,235

‐45.0%

4,053

7,747

‐47.7%

Income tax expense

7

(474)

(329)

44.1%

(1,068)

(944)

13.1%

Profit for the financial

period/year, representing total

comprehensive income for the

financial period/year

755

1,906

‐60.4%

2,985

6,803

‐56.1%

Profit and total comprehensive

income attributable to:

Owners of the parent

739

1,738

‐57.5%

2,790

6,380

‐56.3%

Non‐controlling interests

16

168

‐90.5%

195

423

‐53.9%

755

1,906

‐60.4%

2,985

6,803

‐56.1%

Earnings per share (in cents)

‐ Basic and diluted

9

0.50

1.17

‐57.3%

1.87

4.28

‐56.3%

N.M. - Not meaningful

3

B. Condensed interim statements of financial position

Group

Company

31 May 2023

31 May 2022

31 May 2023

31 May 2022

Note

(Unaudited)

(Audited)

(Unaudited)

(Audited)

S$'000

S$'000

S$'000

S$'000

ASSETS

Non‐current assets

Plant and equipment

11

1,598

1,496

13

12

Intangible assets

12

3,358

4,037

‐

2

Right‐of‐use assets

2,898

2,383

39

99

Investments in subsidiaries

13

‐

‐

13,464

14,339

Investment in associates

14

3,116

480

3,116

480

Investment in joint ventures

182

182

182

182

Debt instruments at amortised cost

‐

1,882

‐

1,882

Financial assets at FVTPL

15

5,850

10,044

5,850

10,044

Deferred tax assets

43

99

‐

‐

Derivative financial instruments

16

1,397

1,242

1,901

1,738

Other receivables

119

‐

155

36

18,561

21,845

24,720

28,814

Current assets

Inventories

445

376

‐

‐

Trade and other receivables

1,749

1,556

2,466

1,909

Prepayments

246

255

95

114

Debt instruments at amortised cost

1,882

‐

1,882

‐

Financial assets at FVTPL

15

2,193

‐

2,193

‐

Cash and bank balances

6,187

6,928

3,205

2,837

12,702

9,115

9,841

4,860

Total assets

31,263

30,960

34,561

33,674

EQUITY AND LIABILITIES

Equity

Share capital

17

15,419

15,419

15,419

15,419

Treasury shares

(996)

(996)

(996)

(996)

Merger reserve

(815)

(815)

‐

‐

Capital reserve

18

(13,652)

(13,652)

(164)

(164)

Other reserve

19

(1,172)

(2,633)

‐

‐

Retained earnings

13,191

13,677

7,310

6,383

Equity attributable to owners of the

parent

11,975

11,000

21,569

20,642

Non‐controlling interests

108

221

‐

‐

Total equity

12,083

11,221

21,569

20,642

4

B. Condensed interim statements of financial position (continued)

Group

Company

31 May 2023

31 May 2022

31 May 2023

31 May 2022

Note

(Unaudited)

(Audited)

(Unaudited)

(Audited)

S$'000

S$'000

S$'000

S$'000

Non‐current liabilities

Deferred tax liabilities

88

98

‐

‐

Derivative financial instruments

16

556

28

556

28

Other financial liabilities

20

578

2,096

‐

‐

Other payables

21

3,204

5,723

3,204

5,723

Bank borrowings

22

1,288

2,550

1,288

2,550

Provisions

144

106

21

21

Lease liabilities

1,897

1,492

36

76

7,755

12,093

5,105

8,398

Current liabilities

Trade and other payables

21

8,096

4,436

6,201

3,060

Bank borrowings

22

1,262

1,237

1,262

1,237

Provisions

13

‐

‐

‐

Lease liabilities

1,049

973

181

198

Current income tax payable

1,005

1,000

243

139

11,425

7,646

7,887

4,634

Total liabilities

19,180

19,739

12,992

13,032

Total equity and liabilities

31,263

30,960

34,561

33,674

5